Lyophilized Injectable Drugs to 2026 • LKD888F • March 2021 • US $3,850
The number of drugs supplied in lyophilized form has been growing at an increased rate over the past several years, mirroring the increase in the introduction of biological drugs. Liquid drugs that require refrigeration until dispensed – a requirement referred to as the ‘Cold Chain’ – can be formulated as powders to avoid the cost and logistics of cold storage. A number of factors are at play that are likely to influence the future demand picture for lyophilized drugs. Perhaps the most important is the underlying dynamics of the pharmaceutical and biotechnology marketplace as they apply to drug formulation and end user requirements.
What You Will Learn
- • Provides detailed analysis of lyophilized drugs, as-supplied packaging and therapeutic indication
• Analyzes therapeutic demand drivers and evaluates lyophilized drugs in eleven therapeutic areas
• Analyzes lyophilization technologies and market development issues
• Provides market data and forecasts to 2026
• Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
• Assesses the importance of technology and regulatory factors on commercialization and market access
Lyophilized Injectable Drugs to 2026 – Summary of Contents
Executive Summary
The Market Opportunity
Delivery Market Dynamics
The Economics of lyophilized Drugs
What’s Driving the Market for Lyophilized Drugs?
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Lyophilized Drugs – Primary Packaging
Single Use Vials
Point-of-Care Reconstitution
Specialty Packaging
Drugs for SC/IM Injection
Drugs for Infusion
Product Specific Devices
Lyophilized Drugs – Reconstitution and Delivery
Prefilled Diluent Syringes
Proprietary Reconstitution Devices
Single Step Devices
Multi-Step Devices
Human Engineering/Ergonomics
Lyophilized Drugs – Key Therapeutic Sector Analysis and Market Data
Antibiotics
Autoimmune Diseases
Blood Factors
Hormones
Infectious Diseases
Metabolic Conditions
Oncology
Reproductive Health
Other Important Therapeutic Classes
Market Factors
Regulatory Issues
Patient Compliance and Ease of Use
Healthcare Economics
Company Profiles
For more information click HERE